NCT07606066ClinicalTrials.gov
A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies
In breve
The purpose of this study is to identify and characterize patients with known Type 2 Diabetes Mellitus (T2DM) for possible participation in ongoing or future T2DM clinical studies, and to characterize trends in key concomitant medication use in this patient…
Osservazionale2150 partecipanti ricercati76 centri7 paesi
Categorie
Registrato in 1 registro
- ClinicalTrials.govNCT07606066Apri questa scheda su ClinicalTrials.govSincronizzato 4 settimane fa
Uno studio può essere registrato in più registri. Lo mostriamo una volta sola e colleghiamo ogni scheda in nostro possesso.
Le informazioni sulla sperimentazione sono mostrate così come pubblicate dal registro, nella lingua originale.
Ti interessa questo studio?
Accedi oppure crea un account per registrare il tuo interesse e seguire questo studio.
How this study is set up
The points below are drawn from the public registry record for this study. Each one cites the field or sentence it came from. A dash (—) means the record does not state something — not that it is missing or wrong. Many well-run studies, especially small ones, leave some of these blank.
- Not stated: Registered after enrolment began (about 20 days after the recorded start)First posted 2026-05-26; recorded start 2026-05-06
- Present: Has a defined primary outcomeA primary outcome measure is listed in the record
- Present: The primary outcome states a time frameThe primary outcome measure records a time frame
- Not stated: Whether participants are randomly assigned is not stated in the registry recordNo allocation method is recorded
- Not stated: A comparison group is not stated in the registry recordThe record describes a single study arm
- Not stated: Whether the study is blinded is not stated in the registry recordNo masking information is recorded
- Not stated: An ethics committee is not stated in the registry recordThis registry's ingested record has no ethics-committee field
- Not stated: Regulatory oversight (such as an IND or IDE) is not stated in the registry recordThis registry's ingested record has no regulatory-authorisation field
- Not stated: A data monitoring committee is not stated in the registry recordThis registry's ingested record has no data-monitoring-committee fieldA data monitoring committee is not required for many smaller studies, and its absence here is not unusual.
- Present: No cost to participants is mentioned in the recordChecked the summary, description and eligibility text; no cost-to-participant phrase found
- Present: Sponsor has 1019 other studies in this databaseCounted from the lead sponsor named in the record (AstraZeneca)
- Present: Sponsor has posted results for at least one studyBased on the sponsor’s studies in this database
- The record lists 1 condition.
- Lead sponsor type recorded as: industry.
Trial stature
Three independent measures of this study, described from its registry record — not a recommendation about it. A rigorous study by investigators nobody has heard of is better evidence than a weak study led by a famous one. How these are scored.
An exploratory-stage design for a study of this type, judged from its ClinicalTrials.gov record.
How this score is built
- Randomised allocation0/20
Allocation not stated in the record
- Blinding0/20
Masking not stated in the record
- Control arm0/15
No comparator arm stated in the record
- Primary-outcome specificity10/10
Named primary outcome with a defined time frame
- Endpoint type3/10
Surrogate or intermediate endpoint (conservative default)
- Multi-centre8/8
Multi-centre: 71 sites
- Data monitoring committee0/7
No data monitoring committee stated
- Prospective registration5/5
Registered before the study start date
- Protocol / SAP posted0/5
No protocol or SAP posted to the registry
A large study, international in scope: 2,150 participants (target), run at 76 sites, across 7 countries.
How this score is built
- Enrolment33/40
2,150 participants (target)
- Site count21/25
71 sites
- Country count12/15
7 countries
- Planned duration5/10
Planned over about 11 months
- Sponsor scale10/10
AstraZeneca has led 991 trials in our corpus
We have no verifiable track record for the investigator named on this trial. That is common for early-career investigators and for records held outside ClinicalTrials.gov — it is not a negative signal.
How this score is built
- Investigator standing0/100
No investigator recorded in the registry for this trial
These describe the registry record only, and today we hold ClinicalTrials.gov data. Absent fields lower a score, and absence often reflects registration practice rather than study quality. A high-stature trial is not necessarily safer or a better choice for you — enrolling in a large definitive trial can mean a higher chance of receiving placebo, while a small early-phase study may be the only route to a new therapy.
Sintesi
The purpose of this study is to identify and characterize patients with known Type 2 Diabetes Mellitus (T2DM) for possible participation in ongoing or future T2DM clinical studies, and to characterize trends in key concomitant medication use in this patient population across different geographical regions.
Patologie
- Type 2 Diabetes
Idoneità
| Sesso | Tutti |
|---|---|
| Età | 18 Years – Nessun massimo |
| Volontari sani | No |
| Metodo di campionamento | NON_PROBABILITY_SAMPLE |
Popolazione dello studio
Adults with Type 2 Diabetes
Idoneità come riportata nel registro
Idoneità in frasi semplici
I criteri di questa scheda non sono ancora stati suddivisi in affermazioni distinte. Il testo del registro qui sopra è completo ed è la versione autorevole.
Disegno dello studio
| Tipo di studio | Osservazionale |
|---|---|
| Fase | Non indicato nella scheda del registro |
| Assegnazione | Non indicato nella scheda del registro |
| Modello di intervento | Non indicato nella scheda del registro |
| Finalità principale | Non indicato nella scheda del registro |
| Mascheramento | Non indicato nella scheda del registro |
| Arruolamento | 2150 partecipanti ricercati |
Sponsor e collaboratori
- AstraZeneca Sponsor
Bracci e interventi
- Participants with Type 2 Diabetes
Participants with Type 2 Diabetes
Interventi
- Altro Procedure: assessment
The approximate volume of blood required is 2 mL
Esiti misurati
Esito primario
Patient demographics
Summary statistics
Orizzonte temporale Visit 1 (Single day)
Esito primario
Medical and surgical history
Summary statistics
Orizzonte temporale Visit 1 (Single day)
Esito primario
Concomitant medication
Summary statistics
Orizzonte temporale Visit 1 (Single day)
Esito primario
HbA1c levels
Summary statistics
Orizzonte temporale Visit 1 (Single day)
Esito secondario
Referral to ongoing or future T2DM study.
Number of participants with high likelihood of meeting eligibility criteria in ongoing or future T2DM studies, for referral to those studies.
Orizzonte temporale Visit 1 (Single day)
Date
| Data di inizio | 6 maggio 2026 (effettiva) |
|---|---|
| Conclusione primaria | 31 marzo 2027 (stimata) |
| Conclusione | 31 marzo 2027 (stimata) |
| Prima pubblicazione | 26 maggio 2026 (effettiva) |
| Ultimo aggiornamento | 25 agosto 2026 |
| Risultati pubblicati | Non indicato nella scheda del registro |
| Stato verificato l'ultima volta | marzo 2026 |
«Effettiva» significa che l'evento è avvenuto. «Stimata» significa che lo sponsor lo prevede. Le due cose non sono equivalenti.
Centri
19 centri stanno reclutando
Brazil
| Struttura | Città | Stato o regione | Stato |
|---|---|---|---|
| Research Site | Barretos | Non ancora in reclutamento | |
| Research Site | Brasília | Non ancora in reclutamento | |
| Research Site | Campinas | São Paulo | Non ancora in reclutamento |
| Research Site | Curitiba | Paraná | In reclutamento |
| Research Site | Fortaleza | Ceará | Non ancora in reclutamento |
| Research Site | Natal | Rio Grande do Norte | Non ancora in reclutamento |
| Research Site | Porto Alegre | Rio Grande do Sul | Non ancora in reclutamento |
| Research Site | Rio de Janeiro | Non ancora in reclutamento | |
| Research Site | São José dos Campos | São Paulo | Non ancora in reclutamento |
| Research Site | São Paulo | São Paulo | Non ancora in reclutamento |
| Research Site | São Paulo | São Paulo | Non ancora in reclutamento |
Hungary
| Struttura | Città | Stato o regione | Stato |
|---|---|---|---|
| Research Site | Budapest | In reclutamento | |
| Research Site | Budapest | Non ancora in reclutamento | |
| Research Site | Budapest | In reclutamento | |
| Research Site | Budapest | HU | In reclutamento |
| Research Site | Budapest | HU | In reclutamento |
| Research Site | Debrecen | HU | Non ancora in reclutamento |
| Research Site | Salgótarján | Non ancora in reclutamento | |
| Research Site | Szeged | HU | Non ancora in reclutamento |
| Research Site | Szolnok | Non ancora in reclutamento | |
| Research Site | Zalaegerszeg | In reclutamento |
India
| Struttura | Città | Stato o regione | Stato |
|---|---|---|---|
| Research Site | Bangalore | Karnataka | Non ancora in reclutamento |
| Research Site | Belagavi | Karnataka | Non ancora in reclutamento |
| Research Site | Belagavi | Karnataka | Non ancora in reclutamento |
| Research Site | Calicut | Kerala | Non ancora in reclutamento |
| Research Site | Chennai | Tamil Nadu | Non ancora in reclutamento |
| Research Site | Coimbatore | Tamil Nadu | Non ancora in reclutamento |
| Research Site | Delhi | New Delhi | Non ancora in reclutamento |
| Research Site | Guntur | Andhra Pradesh | Non ancora in reclutamento |
| Research Site | Guwahati | Assam | Non ancora in reclutamento |
| Research Site | Indore | Madhya Pradesh | Non ancora in reclutamento |
| Research Site | Jaipur | Rajasthan | Non ancora in reclutamento |
| Research Site | Kochi | Kerala | Non ancora in reclutamento |
| Research Site | Kolkata | West Bengal | Non ancora in reclutamento |
| Research Site | Lucknow | Uttar Pradesh | Non ancora in reclutamento |
| Research Site | Mumbai | Maharashtra | Non ancora in reclutamento |
| Research Site | Nagpur | Maharashtra | Non ancora in reclutamento |
| Research Site | Pune | Maharashtra | Non ancora in reclutamento |
| Research Site | Pune | Maharashtra | Non ancora in reclutamento |
| Research Site | Thiruvananthapuram | Kerala | Non ancora in reclutamento |
Malaysia
| Struttura | Città | Stato o regione | Stato |
|---|---|---|---|
| Research Site | Batu Caves | Selangor | Ritirato |
| Research Site | Kuala Lumpur | Wilayah Persekutuan Kuala Lump | Non ancora in reclutamento |
| Research Site | Putrajaya | Non ancora in reclutamento | |
| Research Site | Seremban | Negeri Sembilan | In reclutamento |
| Research Site | Seri Manjung | Perak | Non ancora in reclutamento |
Poland
| Struttura | Città | Stato o regione | Stato |
|---|---|---|---|
| Research Site | Bialystok | Podlaskie Voivodeship | In reclutamento |
| Research Site | Częstochowa | Silesian Voivodeship | Non ancora in reclutamento |
| Research Site | Kielce | Świętokrzyskie Voivodeship | Non ancora in reclutamento |
| Research Site | Krakow | Malopolska | Non ancora in reclutamento |
| Research Site | Lodz | Łódź Voivodeship | In reclutamento |
Nella scheda del registro sono indicati altri 26 centri.
Documenti dello studio
In questa scheda del registro non sono collegati documenti.
Modifiche nel tempo
- 25 agosto 2026
Centro aggiunto
5 sites added (76 total)
7176